Date | Insider | Price | Amount |
---|---|---|---|
12-3-2015 Insider Buy |
Scott D. Morenstein Director |
$1.86 CAGR » |
$9,325.00 5,000 shares |
10-6-2015 Insider Buy |
Scott Thomas Jackson Chief Executive Officer |
$1.74 CAGR » |
$25,143.00 14,450 shares |
10-5-2015 Insider Buy |
Fred M. Powell VP and Chief Financial Officer |
$1.78 CAGR » |
$24,386.00 13,700 shares |
10-1-2015 Insider Buy |
Valence Life Sciences GP II LLC |
$1.64 CAGR » |
$20,054.00 12,200 shares |
11-18-2014 Insider Buy |
Michael R. Dougherty Director |
$2.15 CAGR » |
$42,940.00 20,000 shares |
11-18-2014 Insider Buy |
Scott Thomas Jackson Chief Executive Officer |
$2.20 CAGR » |
$22,000.00 10,000 shares |
11-18-2014 Insider Buy |
Fred M. Powell Chief Financial Officer |
$2.20 CAGR » |
$13,200.00 6,000 shares |
5-15-2014 Insider Buy |
Fred M. Powell Chief Financial Officer |
$2.50 CAGR » |
$6,240.00 2,500 shares |
12-17-2013 Insider Buy |
Scott Thomas Jackson Chief Executive Officer |
$3.50 CAGR » |
$10,490.40 3,000 shares |
12-17-2013 Insider Buy |
Fred M. Powell VP and CFO |
$3.50 CAGR » |
$8,750.00 2,500 shares |
Also See: Institutional Holders of CPXX
Also See: SEC filings
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 12/04/2015 | ||
End date: | 07/13/2016 | ||
Start price/share: | $1.80 | ||
End price/share: | $0.00 | ||
Starting shares: | 5,555.56 | ||
Ending shares: | 5,555.56 | ||
Dividends reinvested/share: | $30.25 | ||
Total return: | -100.00% | ||
Annualized Gain: | -165.16% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $0.00 | ||
Years: | 0.61 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 12/04/2015 | ||
End date: | 07/13/2016 | ||
Start price/share: | $1.80 | ||
End price/share: | $0.00 | ||
Dividends collected/share: | $30.25 | ||
Total return: | 1,580.56% | ||
Annualized Gain: | 2,610.42% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $168,056.00 | ||
Years: | 0.61 |
CPXX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CPXX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CPXX
Free CPXX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |